First Time Loading...

MaxCyte Inc
LSE:MXCT

Watchlist Manager
MaxCyte Inc Logo
MaxCyte Inc
LSE:MXCT
Watchlist
Price: 297 GBX Market Closed
Updated: May 5, 2024

Income Statement

Earnings Waterfall
MaxCyte Inc

Revenue
41.3m USD
Cost of Revenue
-4.7m USD
Gross Profit
36.5m USD
Operating Expenses
-84.8m USD
Operating Income
-48.3m USD
Other Expenses
10.4m USD
Net Income
-37.9m USD

Income Statement
MaxCyte Inc

Rotate your device to view
Income Statement
Currency: USD
Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023
Revenue
Revenue
39
N/A
41
+6%
42
+1%
44
+5%
41
-7%
41
-1%
38
-6%
41
+9%
Gross Profit
Cost of Revenue
(4)
(4)
(5)
(5)
(5)
(5)
(5)
(5)
Gross Profit
35
N/A
37
+6%
37
+0%
39
+5%
36
-8%
35
-2%
33
-6%
37
+10%
Operating Income
Operating Expenses
(51)
(57)
(63)
(67)
(73)
(76)
(80)
(85)
Selling, General & Administrative
(36)
(41)
(43)
(44)
(48)
(50)
(53)
(57)
Research & Development
(13)
(15)
(17)
(20)
(22)
(23)
(24)
(24)
Depreciation & Amortization
(2)
(2)
(3)
(3)
(3)
(3)
(4)
(4)
Operating Income
(16)
N/A
(20)
-27%
(26)
-26%
(27)
-7%
(36)
-33%
(41)
-12%
(47)
-15%
(48)
-3%
Pre-Tax Income
Interest Income Expense
(0)
0
2
4
6
8
10
10
Pre-Tax Income
(16)
N/A
(20)
-24%
(24)
-19%
(24)
+0%
(30)
-29%
(33)
-7%
(37)
-15%
(38)
-1%
Net Income
Tax Provision
0
0
0
0
0
0
0
0
Income from Continuing Operations
(16)
(20)
(24)
(24)
(30)
(33)
(37)
(38)
Net Income (Common)
(16)
N/A
(20)
-24%
(24)
-19%
(24)
+0%
(30)
-29%
(33)
-7%
(37)
-15%
(38)
-1%
EPS (Diluted)
-0.17
N/A
-0.2
-18%
-0.23
-15%
-0.23
N/A
-0.3
-30%
-0.32
-7%
-0.37
-16%
-0.37
N/A

See Also

Discover More